z-logo
open-access-imgOpen Access
Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia
Author(s) -
Michael A. Pfaller,
Rodrigo E. Mendes,
Hélio S. Sader,
R. N. Jones
Publication year - 2010
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkq335
Subject(s) - pneumonia , medicine , ventilator associated pneumonia , microbiology and biotechnology , antimicrobial , respiratory tract infections , respiratory tract , gram positive cocci , antibacterial agent , antibiotics , bacteria , respiratory system , biology , staphylococcus aureus , genetics
The antimicrobial activity of telavancin against 2279 clinical Gram-positive cocci obtained from patients with nosocomial pneumonia [NP; including those with ventilator-acquired pneumonia (VAP)] located in numerous medical centres worldwide was evaluated.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom